Dashboard
High Management Efficiency with a high ROE of 58.76%
Company has a low Debt to Equity ratio (avg) at times
Healthy long term growth as Net Sales has grown by an annual rate of 12.92% and Operating profit at 17.16%
With a growth in Net Profit of 29.27%, the company declared Outstanding results in Jun 25
With ROE of 49.02%, it has a attractive valuation with a 26.58 Price to Book Value
Stock DNA
Industrial Manufacturing
USD 306,159 Million (Large Cap)
54.00
NA
0.04%
-0.19
54.33%
31.05
Total Returns (Price + Dividend) 
Lam Research Corp. for the last several years.
Risk Adjusted Returns v/s 
News

Lam Research Corp. Achieves 102.5% Stock Surge, Establishing It as a Multibagger Performer
Lam Research Corp. has recently undergone a revision in its score, reflecting its impressive performance metrics and strong market position. The company has achieved significant returns over the past year, outpacing broader market indices, while maintaining robust financial health and operational efficiency. Its solid fundamentals continue to attract investor interest.
Read MoreIs Lam Research Corp. overvalued or undervalued?
As of 17 October 2025, the valuation grade for Lam Research Corp. has moved from expensive to attractive, indicating a shift towards a more favorable assessment of its stock. The company appears to be undervalued based on its strong performance metrics, including a P/E ratio of 54, an EV to EBITDA ratio of 44.43, and a remarkable ROCE of 61.92%. In comparison to its peers, Lam Research Corp. has a lower P/E ratio than GE Aerospace, which stands at 136.79, and is more attractive than Applied Materials, Inc., which has a P/E of 45.37. The company's recent stock performance has significantly outpaced the S&P 500, with a year-to-date return of 95.92% compared to the index's 13.30%, reinforcing the notion that it is currently undervalued....
Read More
Lam Research Corp. Experiences Revision in Its Stock Evaluation Amid Strong Performance Metrics
Lam Research Corp. has recently adjusted its valuation, showcasing strong financial metrics with a P/E ratio of 54 and a price-to-book value of 26.58. The company demonstrates impressive profitability, highlighted by a ROCE of 61.92% and a ROE of 49.02%, outperforming the S&P 500 significantly.
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 211 Schemes (38.15%)
Held by 558 Foreign Institutions (22.35%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
QoQ Growth in quarter ended Jun 2025 is 9.56% vs 7.87% in Mar 2025
QoQ Growth in quarter ended Jun 2025 is 29.26% vs 11.73% in Mar 2025
Annual Results Snapshot (Consolidated) - Jun'25
YoY Growth in year ended Jun 2025 is 23.68% vs -14.47% in Jun 2024
YoY Growth in year ended Jun 2025 is 39.98% vs -15.14% in Jun 2024






